| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/13/2000 | EP0764166B1 Corticotropin releasing factor antagonists |
| 09/13/2000 | CN1266434A 1,2,4-triazolo [4,3-B] pyrido [3,2-D] pyridazine derivatives and pharmaceutical compositions containing them |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266423A 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 09/13/2000 | CN1266368A Heterocyclic vinylethers against neurological disorders |
| 09/13/2000 | CN1266100A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265917A Medicine for treating lithiasis |
| 09/13/2000 | CN1265916A Chinese patent drug for treating peridentitis |
| 09/13/2000 | CN1265915A Health-care product soluble granules made of 24 Chinese medicinal and making method thereof |
| 09/13/2000 | CN1265899A Medicine for treating cholecystitis |
| 09/13/2000 | CN1265893A Powder medicine for softening liver and eliminating ascites |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056310C Granule medicine for treating gallbladder, pancreas and stomach diseases |
| 09/13/2000 | CN1056304C Medicine for treating hepatitis B |
| 09/13/2000 | CN1056300C Oral traditional Chinese medicine composition for treating gastric cancer |
| 09/13/2000 | CN1056294C Refreshing tea |
| 09/12/2000 | US6117998 A1 adenosine receptor antagonists |
| 09/12/2000 | US6117913 Administering creosote or a phenolic derivative of creosote. |
| 09/12/2000 | US6117908 Use of GABAB receptor agonists as reflux inhibitors |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | US6117868 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117412 Administering bismuth compound containing additional heavy atom as contrast enhancer; x-rays, magnetic resonance, ultrasound, and scintigraphic imaging |
| 09/08/2000 | WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000052041A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052002A1 N-substituted imide derivatives with serotonergic activity |
| 09/08/2000 | WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs |
| 09/08/2000 | WO2000051644A1 TREATMENT OF DIARRHEA CAUSED BY ENTEROPATHOGENIC $i(ESCHERICHIA COLI) |
| 09/08/2000 | WO2000051631A2 Pegylated alpha interferon for hiv therapy |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051597A1 Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss |
| 09/08/2000 | WO2000051584A2 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | WO2000051583A2 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | WO2000051563A1 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000010526A3 New oral formulation for 5-ht4 agonists or antagonists |
| 09/08/2000 | CA2363169A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362825A1 Cdna for human methylenetetrahydrofolate reductase |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362501A1 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362488A1 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/08/2000 | CA2362480A1 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter |
| 09/08/2000 | CA2361182A1 N-substituted imide derivatives with serotonergic activity |
| 09/08/2000 | CA2359754A1 Treatment or diarrhea caused by enteropathogenic escherichia coli |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033129A1 Antimicrobials |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032671A1 Mammalian cytokine-like polypeptide-10 |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032582A1 NOVEL recJ |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032569A1 Imidazole derivatives, preparation and therapeutic application thereof |
| 09/06/2000 | EP1032561A1 Substituted oximes as neurokinin antagonists |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032555A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032413A1 Chemoprotective bacterial strains |
| 09/06/2000 | EP1032408A1 Galenic preparation for prevention and treatment of hepatocarcinoma |
| 09/06/2000 | EP1032405A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 09/06/2000 | EP1032398A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032381A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 09/06/2000 | EP0770089B1 Growth differentiation factor-12 |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0702672B1 Substituted quinoline derivatives and their use as inhibitors of gastric acid secretion |
| 09/06/2000 | EP0665844B1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265643A Anthranilic acid analogs |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels |
| 09/06/2000 | CN1265314A Liver-invigorating detoxication pill for treating hepatitis B |
| 09/06/2000 | CN1056180C Drink and manufacture thereof |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056078C Traditional Chinese medicine for treatment of stomach trouble |
| 09/06/2000 | CN1056076C Prepn. of injection with Radix Sophorae flavescentis and Radix pulsatillae |
| 09/06/2000 | CN1056071C Hepatitis virus inhibitor and prepn. method thereof |
| 09/06/2000 | CN1056069C Traditional Chinese medicine for relaxing liver and strengthening stomach |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |